T1	Participants 0 78	Effects of nifedipine and nitrendipine on insulin secretion in obese patients.
T2	Participants 92 190	influence of calcium antagonists on glucose tolerance and insulin release in humans are conflictin
T3	Participants 294 348	short-term (7 days) treatment with nitrendipine, 20 mg
T4	Participants 371 387	20 mg once daily
T5	Participants 515 554	hypertensive nondiabetic obese patients
T6	Participants 556 669	No statistically significant differences were found in fasting glucose, insulin, and C-peptide, or in the glucose
T7	Participants 960 1124	calcium antagonists have no clinically relevant effect on glucose homeostasis even if a slight alteration of insulin release after glucose load cannot be ruled out.
